{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:46:17Z","timestamp":1789411577371,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.clim.2006.06.001","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T07:55:22Z","timestamp":1153814122000},"page":"243-250","source":"Crossref","is-referenced-by-count":70,"title":["The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus"],"prefix":"10.1016","volume":"121","author":[{"given":"Jim C.","family":"Oates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Gilkeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.06.001_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/152308602753625924","article-title":"Reactive nitrogen and oxygen intermediates and bacterial defenses: unusual adaptations in Mycobacterium tuberculosis","volume":"4","author":"Zahrt","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.clim.2006.06.001_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/ars.2006.8.681","article-title":"Current concepts of redox signaling in the lungs","volume":"8","author":"Rahman","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.clim.2006.06.001_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/0264-6021:3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2006.06.001_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2004.07.030","article-title":"Regulation of the expression of inducible nitric oxide synthase","volume":"500","author":"Kleinert","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.clim.2006.06.001_bib5","unstructured":"E. Karpuzoglu, S.A. Ahmed, Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis, Nitric Oxide (in press) (Electronic publication ahead of print)."},{"key":"10.1016\/j.clim.2006.06.001_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/clim.2000.4985","article-title":"Prostaglandin J(2) inhibition of mesangial cell iNOS expression","volume":"98","author":"Reilly","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2006.06.001_bib7","series-title":"Nitric Oxide in Health and Disease","author":"Lincoln","year":"1997"},{"key":"10.1016\/j.clim.2006.06.001_bib8","unstructured":"Human Proteome Resource Program, NOS2A in normal tissues; [accessed May 19, 2006], Available from: http:\/\/www.hpr.se\/tissue_profile.php?antibody_id=2014"},{"key":"10.1016\/j.clim.2006.06.001_bib9","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.94.13.6954","article-title":"Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages","volume":"94","author":"Xia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.06.001_bib10","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1097\/01.ASN.0000034908.43113.5D","article-title":"Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis","volume":"13","author":"Gaertner","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2006.06.001_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2005.03.010","article-title":"Heme oxygenase and the cardiovascular\u2013renal system","volume":"39","author":"Abraham","year":"2005","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1515\/BC.2002.045","article-title":"Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis","volume":"383","author":"Boyd","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/j.clim.2006.06.001_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.it.2004.05.001","article-title":"Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity","volume":"25","author":"Perl","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2006.06.001_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/pr.57.2.1","article-title":"Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors","volume":"57","author":"Mollace","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.clim.2006.06.001_bib15","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1074\/jbc.M208080200","article-title":"Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase","volume":"278","author":"Schmidt","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2006.06.001_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.179.2.651","article-title":"The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr\/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-l-arginine","volume":"179","author":"Weinberg","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/BF03402193","article-title":"Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr\/lpr mice","volume":"6","author":"Keng","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib18","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/keh722","article-title":"Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model","volume":"44","author":"Delgado Alves","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2006.06.001_bib19","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1681\/ASN.V8111712","article-title":"Role of nitric oxide in rat nephrotoxic nephritis: comparison between inducible and constitutive nitric oxide synthase","volume":"8","author":"Bremer","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2006.06.001_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1523-1755.1998.00780.x","article-title":"Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis","volume":"53","author":"Heeringa","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2006.06.001_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.ASN.0000119962.69573.CC","article-title":"Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis","volume":"15","author":"Ohse","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2006.06.001_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1523-1755.2002.00230.x","article-title":"Modulation of renal disease in MRL\/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase","volume":"61","author":"Reilly","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2006.06.001_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/clin.1997.4332","article-title":"Effect of late modulation of nitric oxide production on murine lupus","volume":"83","author":"Oates","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2006.06.001_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2249.2004.02594.x","article-title":"Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody","volume":"138","author":"Takeda","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2006.06.001_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1191\/0961203302lu214oa","article-title":"Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL\/lpr mice","volume":"11","author":"Lui","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2006.06.001_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1067\/mlc.2001.115647","article-title":"Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL\/lpr mice","volume":"138","author":"Yu","year":"2001","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI16153","article-title":"Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse","volume":"111","author":"Mishra","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.06.001_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.186.3.365","article-title":"Clinical and serologic manifestations of autoimmune disease in MRL-lpr\/lpr mice lacking nitric oxide synthase type 2","volume":"186","author":"Gilkeson","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10623320490482619","article-title":"Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus","volume":"11","author":"Zou","year":"2004","journal-title":"Endothelium"},{"key":"10.1016\/j.clim.2006.06.001_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI0214442","article-title":"Oxidation of the zinc\u2013thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite","volume":"109","author":"Zou","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.06.001_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1084\/jem.179.4.1317","article-title":"Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes","volume":"179","author":"Casciola-Rosen","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2310\/6650.2004.12395","article-title":"Nitric oxide induces apoptosis in spleen lymphocytes from MRL\/lpr mice","volume":"52","author":"Oates","year":"2004","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib33","first-page":"475","article-title":"Lupus in the Fas lane?","volume":"29","author":"Singh","year":"1995","journal-title":"J. R. Coll. Physicians Lond."},{"key":"10.1016\/j.clim.2006.06.001_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2004.07.004","article-title":"Immunogenicity of autologous IgG bearing the inflammation-associated marker 3-nitrotyrosine","volume":"96","author":"Ohmori","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2006.06.001_bib35","article-title":"Peroxynitrite modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies","author":"Habib Moinuddin","year":"2005","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.clim.2006.06.001_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/0961203304lu492oa","article-title":"Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus","volume":"13","author":"Dixit","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2006.06.001_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2310\/6650.2005.53705","article-title":"Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis","volume":"53","author":"Njoku","year":"2005","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib38","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1046\/j.1523-1755.1998.00907.x","article-title":"Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis","volume":"53","author":"Furusu","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2006.06.001_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000190316","article-title":"Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis","volume":"77","author":"Wang","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.clim.2006.06.001_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1525-1381.1999.99110.x","article-title":"Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity","volume":"111","author":"Oates","year":"1999","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.clim.2006.06.001_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.1998.00253.x","article-title":"Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus","volume":"111","author":"Kuhn","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2006.06.001_bib42","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/art.1780401013","article-title":"Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus","volume":"40","author":"Belmont","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2006.06.001_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002960050055","article-title":"Nitric oxide synthesis is increased in patients with systemic lupus erythematosus","volume":"18","author":"Wanchu","year":"1998","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2006.06.001_bib44","first-page":"318","article-title":"Correlation of serum measures of nitric oxide production with lupus disease activity","volume":"26","author":"Gilkeson","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2006.06.001_bib45","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1529-0131(200005)43:5<1085::AID-ANR19>3.0.CO;2-7","article-title":"Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis\u2014findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1","volume":"43","author":"Andersen","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2006.06.001_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/rheumatology\/keg045","article-title":"Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus","volume":"42","author":"Ho","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2006.06.001_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1475-097X.1996.tb00726.x","article-title":"Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors","volume":"16","author":"Jungersten","year":"1996","journal-title":"Clin. Physiol."},{"key":"10.1016\/j.clim.2006.06.001_bib48","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/art.21130","article-title":"Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2006.06.001_bib49","first-page":"60","article-title":"Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in African-Americans","volume":"30","author":"Oates","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2006.06.001_bib50","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0140-6736(02)11474-7","article-title":"A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children","volume":"360","author":"Hobbs","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2006.06.001_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/niox.2000.0290","article-title":"Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease","volume":"4","author":"Xu","year":"2000","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.clim.2006.06.001_bib52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/322037","article-title":"Nitric oxide synthase 2 (G-954C), increased nitric oxide production, and protection against malaria","volume":"184","author":"Kun","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2006.06.001_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/BA20050156","article-title":"Peroxynitrite-modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies","volume":"43","author":"Habib Moinuddin","year":"2006","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.clim.2006.06.001_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5483\/BMBRep.2006.39.2.189","article-title":"Antibodies against nitric oxide damaged poly l-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus","volume":"39","author":"Khan","year":"2006","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.clim.2006.06.001_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/152308603764816523","article-title":"The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways","volume":"5","author":"Huber","year":"2003","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.clim.2006.06.001_bib56","doi-asserted-by":"crossref","first-page":"C1619","DOI":"10.1152\/ajpcell.1993.264.6.C1619","article-title":"Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells","volume":"264","author":"Fukunaga","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.clim.2006.06.001_bib57","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1196\/annals.1361.073","article-title":"OxLDL\/\u03b22GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement","volume":"1051","author":"Lopez","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2006.06.001_bib58","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI118288","article-title":"Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells","volume":"96","author":"Heery","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.06.001_bib59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/01.RES.0000032114.68919.EF","article-title":"Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells","volume":"91","author":"Coles","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2006.06.001_bib60","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1074\/jbc.M105209200","article-title":"Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP","volume":"277","author":"Coles","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2006.06.001_bib61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0895-7061(01)02242-7","article-title":"Assessment of endothelial function of the renal vasculature in human subjects","volume":"15","author":"Delles","year":"2002","journal-title":"Am. J. Hypertens"},{"key":"10.1016\/j.clim.2006.06.001_bib62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.niox.2004.10.005","article-title":"Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements","volume":"11","author":"Kirchner","year":"2004","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.clim.2006.06.001_bib63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2249.1998.00632.x","article-title":"Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-\u03b21) mRNA expression and diminishes glomerulosclerosis in NZB\/W F1 mice","volume":"113","author":"Yang","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2006.06.001_bib64","unstructured":"Glaxo-Smith-Kline, Product Development Pipeline, February 2006; [accessed May 19, 2006], Available from: http:\/\/www.gsk.com\/financial\/product_pipeline\/docs\/pipeline.pdf."},{"key":"10.1016\/j.clim.2006.06.001_bib65","unstructured":"National Library of Medicine, ClinicalTrials.gov; [accessed May 19, 2006], Available from: http:\/\/www.ClinicalTrials.gov."},{"key":"10.1016\/j.clim.2006.06.001_bib66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1074\/jbc.M105691200","article-title":"Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors","volume":"277","author":"Blasko","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2006.06.001_bib67","doi-asserted-by":"crossref","first-page":"H2524","DOI":"10.1152\/ajpheart.00530.2003","article-title":"A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice","volume":"285","author":"Ichinose","year":"2003","journal-title":"Am. J. Physiol.: Heart Circ. Physiol."},{"key":"10.1016\/j.clim.2006.06.001_bib68","doi-asserted-by":"crossref","first-page":"H2430","DOI":"10.1152\/ajpheart.00055.2003","article-title":"Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury","volume":"285","author":"Enkhbaatar","year":"2003","journal-title":"Am. J. Physiol.: Heart Circ. Physiol."},{"key":"10.1016\/j.clim.2006.06.001_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/diabetes.51.2.347","article-title":"A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone","volume":"51","author":"Piganelli","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2006.06.001_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.freeradbiomed.2003.10.029","article-title":"Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation\u2013reduction reactions in innate immunity","volume":"36","author":"Tse","year":"2004","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.clim.2006.06.001_bib71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ana.20552","article-title":"Manganese porphyrin given at symptom onset markedly extends survival of ALS mice","volume":"58","author":"Crow","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2006.06.001_bib72","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.autrev.2004.11.011","article-title":"Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins","volume":"4","author":"Ohmori","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2006.06.001_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijbiomac.2005.02.005","article-title":"Acquired antigenicity of DNA after modification with peroxynitrite","volume":"35","author":"Habib","year":"2005","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.clim.2006.06.001_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(97)00001-5","article-title":"The isoprostanes: unique bioactive products of lipid peroxidation","volume":"36","author":"Morrow","year":"1997","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.clim.2006.06.001_bib75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","article-title":"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations","volume":"52","author":"Frostegard","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2006.06.001_bib76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/15216540500137701","article-title":"Reactivity of peroxynitrite and nitric oxide with LDL","volume":"57","author":"Botti","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.clim.2006.06.001_bib77","unstructured":"J.C. Oates, G.S. Gilkeson, Nitric Oxide in SLE, in: Tsokos GC, Gordon C, Smolen JS: (Eds). Systemic Lupus Erythematosus: A Companion to Rheumatology, ed. Elsevier, 2006 (in press) (ISBN: 0323044344ISBN-13: 9780323044349)."},{"key":"10.1016\/j.clim.2006.06.001_bib78","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-2952(95)02099-3","article-title":"Selective pharmacological inhibition of distinct nitric oxide synthase isoforms","volume":"51","author":"Southan","year":"1996","journal-title":"Biochem. Pharmacol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606007674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606007674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T02:50:37Z","timestamp":1627613437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661606007674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S1521661606007674"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.06.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}